Pojednic Rachele M, Trussler Emily M, Navon Julia D, Lemire Sarah C, Siu Elizabeth C, Metallinos-Katsaras Elizabeth S
Simmons University, Boston, Massachusetts, USA.
Norwich University, Northfield, Vermont, USA.
Diabetes Metab Res Rev. 2022 Mar;38(3):e3499. doi: 10.1002/dmrr.3499. Epub 2021 Oct 11.
To examine the association between vitamin D (25(OH)D) deficiency and risk of prediabetes in Americans 50+ years of age.
This was a cross-sectional analysis of NHANES (2007-2012) subjects aged 50+ years, free of kidney/liver diseases and diabetes. Prediabetes was defined as: HbA1c level 5.7%-6.4%, or fasting plasma glucose level 100-125 mg/dL, or Oral Glucose Tolerance Test result 140-199 mg/dL, with no laboratory value in the diabetic range. The comparison group had normal glucose tolerance (NGT) with no marker in the prediabetes/diabetes range. Total serum 25(OH)D levels were deficient at <50 nmol/L, insufficient 50-75 nmol/L, and sufficient >75 nmol/L. Logistic regression included strata, cluster and weight variables. Models were adjusted for body mass index (BMI), ethnicity, age and gender.
The final sample was 2286 adults, predominantly White (80.4%) and female (56.6%), with a mean age of 62.3 years. Within the sample, 1387 had prediabetes (59.1%) and 899 were NGT (40.9%). Individuals classified within a lower serum vitamin D category were more likely to have prediabetes (p = 0.03). Those with 25(OH)D deficiency were more likely to have prediabetes compared to 25(OH)D sufficient individuals (crude OR = 1.48, 95% CI 1.15-1.91), and this association remained significant after adjustment for ethnicity, BMI, age and gender (aOR = 1.39, 95% CI 1.02-1.89). There was no effect modification by BMI, gender or ethnicity.
Vitamin D status was associated with risk of prediabetes in this sample of Americans 50+ years of age. Future research should seek to understand the potential mechanistic relationship between vitamin D and prediabetes.
研究50岁及以上美国人中维生素D(25羟维生素D)缺乏与糖尿病前期风险之间的关联。
这是一项对2007 - 2012年美国国家健康与营养检查调查(NHANES)中50岁及以上、无肾脏/肝脏疾病和糖尿病的受试者进行的横断面分析。糖尿病前期定义为:糖化血红蛋白(HbA1c)水平5.7% - 6.4%,或空腹血糖水平100 - 125毫克/分升,或口服葡萄糖耐量试验结果140 - 199毫克/分升,且无糖尿病范围内的实验室值。对照组为糖耐量正常(NGT)且无糖尿病前期/糖尿病范围内标志物的人群。血清总25(OH)D水平<50纳摩尔/升为缺乏,50 - 75纳摩尔/升为不足,>75纳摩尔/升为充足。逻辑回归纳入了分层、聚类和权重变量。模型对体重指数(BMI)、种族、年龄和性别进行了调整。
最终样本为2286名成年人,主要为白人(80.4%)和女性(56.6%),平均年龄62.3岁。样本中,1387人患有糖尿病前期(59.1%),899人为糖耐量正常(40.9%)。血清维生素D类别较低的个体更有可能患有糖尿病前期(p = 0.03)。与25(OH)D充足的个体相比,25(OH)D缺乏的个体更有可能患有糖尿病前期(粗比值比[OR]=1.48,95%置信区间[CI] 1.15 - 1.91),在对种族、BMI、年龄和性别进行调整后,这种关联仍然显著(调整后OR = 1.39,95% CI 1.02 - 1.89)。BMI、性别或种族未产生效应修饰作用。
在这个50岁及以上的美国人群样本中,维生素D状态与糖尿病前期风险相关。未来的研究应致力于了解维生素D与糖尿病前期之间潜在的机制关系。